Table 1 Clinicopathological features of patients.
From: Cellular senescence drives age-dependent hepatic steatosis
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
Age at diagnosis, years | 66 | 68 | 26 | 36 | 55 | 52 | 58 | 45 | 41 |
Gender | F | F | F | M | F | F | F | M | M |
Steatosis grade | 1 | 2 | 1 | 1 | 2 | 2 | 3 | 1 | 3 |
% Steatotic hepatocytes | 8 | 40 | 10 | 10 | 35 | 35 | 80 | 10 | 70 |
Acinar zone | 3 | 2+3 | Non-zonal | 3 | 3 | 3 | Pan-zonal | Non-zonal | 2+3 |
Hepatocyte ballooning | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Lobular inflammation | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Portal inflammation | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Nuclear glycogenation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Megamitochondria | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Lipogranulomas | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 |
SAF activity score | 1 | 2 | 0 | 1 | 1 | 1 | 2 | 1 | 1 |
NAS score | 2 | 4 | 1 | 2 | 3 | 3 | 5 | 2 | 4 |
Fibrosis stage | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
